The Cardiology Department was aware of the presence of an AquaVENT® FD140i device in the hospital and expressed an interest in assessing its potential advantages within their unit. Following training provided by Armstrong Medical, the unit’s staff discovered the device’s complete capabilities and how it could benefit their patients.
Male patient in his early 20s presented to our coronary care department following chest trauma secondary to a fall.
Presenting symptoms were:
Patient was treated for community acquired pneumonia, hypoxia, pericardial and pleural effusions. On admission to coronary care, patient desaturated and required CPAP.
We have recently changed our CPAP to Armstrong Medical’s AquaVENT® FD140i as it has the advantage of being able to switch between CPAP and high flow nasal specs, depending on the patient’s condition.
Being fairly new to CPAP we required additional support from Armstrong Medical’s Training Team. Initially we encountered a few issues with alarms but with David’s support we identified these alarms were due to a poor seal from mask to facial contour. We also required support understanding the various CPAP settings. David was very patient and provided teaching sessions to all staff. He was also on hand for any issues that arose. The patient required CPAP for 48hrs.
We were able to wean the patient’s CPAP until he no longer required any oxygen therapy. Having the high flow nasal oxygen incorporated in the function of the machine meant that when the patient was having his meals or required a break from CPAP we could use high flow nasal oxygen.
Download Case Study
ALTNAGELVIN AREA HOSPITAL,
NORTHERN IRELAND
Marie McGrellis
Cardiology Ward Manager
Cardiology Department
THERAPIES
Armstrong Medical Ltd is a limited company registered in Northern Ireland
Wattstown Business Park, Newbridge Road, Coleraine, Co. Derry/Londonderry, BT52 1BS, United Kingdom
VAT Number: GB432578934
Company Number: NI025560